Professor, Department of Hematology and Oncology, Samsung Medical Center

Speciality Interests

Colorectal Cancer

Schedule

schedule of week
04 MON
29
TUE
30
WEN
01
THU
02
FRI
03
AM available available
PM

Medical School

1998~1999 Ph.D. in Medicine Graduate School, Korea University College of Medicine, Seoul, Korea 1982~1986 M.D. Seoul National University College of Medicine, Seoul, Korea

Specialty Training

Specialty Training
Fellowship   1990~1991 Hematology and Medical Oncology, Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
Residency   1987~1990 Seoul National University Hospital, Seoul, Korea
Internship   Seoul National University Hospital

Other Education

  • 2004~2010 Chief Clinical Trial Training Center Clinical Trial Center, Samsung Medical Center, Seoul, Korea
    2000~2003 Chief Center for Clinical Trials, National Cancer Center Hospital, Kyonggi, Korea
    1999~2000 Associate Professor Department of Internal Medicine, Halllym University College of Medicine
    1996~1997 Consultant University of Pittsburgh National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, USA
    1993 Clinical Fellow Fred Hutchinson Cancer Research Center, Seattle, USA

Participation in Academic Societies
and Research

  • Member Korean Society of Medical Oncology
    Member Korean Cancer Association
    Member American Society of Clinical Oncology

Thesis

INVEST NEW DRUG 2021 10.1007/s10637-021-01110-9

A phase 1 dose-escalation and dose-expansion study to assess the safety and efficacy of CKD-516, a novel vascular disrupting agent, in combination with Irinotecan in patients with previously treated metastatic colorectal cancer

Jeong1, H; Hong, YS; Kim, JE; Lim, HS; Ahn, JB; Shin, SJ; Park, YS; Kim, ST; Han, SW; Kim, TY; Kim, TW

ONCOLOGY-BASEL 2021 10.1159/000514404

Programmed Death Ligand 1 Expression as a Prognostic Marker in Patients with Advanced Biliary Tract Cancer

Kim1, H; Kim, J; Byeon, S; Jang, KT; Hong, JY; Lee, JY; Park, SH; Park, JO; Park, YS; Lim, HY; Kang, WK; Kim, ST

ANN ONCOL 2021 10.1016/j.annonc.2020.11.017

A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial

Park1, SH; Lim, DH; Sohn, TS; Lee, J; Zang, DY; Kim, ST; Kang, JH; Oh, SY; Hwang, IG; Ji, JH; Shin, DB; Yu, JI; Kim, KM; An, JY; Choi, MG; Lee, JH; Kim, S; Hong, JY; Park, JO; Park, YS; Lim, HY; Bae, JM; Kang, WK

ONCOLOGIST 2021 10.1002/onco.13735

Proton Pump Inhibitor Use and the Efficacy of Chemotherapy in Metastatic Colorectal Cancer: A Post Hoc Analysis of a Randomized Phase III Trial (AXEPT)

Kim1, SY; Lee, JS; Kang, J; Morita, S; Park, YS; Sakamoto, J; Muro, K; Xu, RH; Kim, TW

THER ADV MED ONCOL 2021 10.1177/1758835921992992

Clinical sequencing to assess tumor mutational burden as a useful biomarker to immunotherapy in various solid tumors

Kim1, H; Hong, JY; Lee, J; Park, SH; Park, JO; Park, YS; Lim, HY; Kang, WK; Kim, KM; Kim, ST

CLOSE

Patients' Rights and Responsibilities

Patients' Rights

1. Right to receive medical care

Patients have the right to receive proper care in a safe setting without discrimination nor should their right to care be violated regardless of their gender, age, religion, social status, nationality, language, race, or physical/mental/financial status. Medical teams shall not refuse to provide care without justifiable reason.

2. Right to be informed and to make an autonomous decision

Patients have the right to obtain full and complete information from their medical team, to ask questions, and to determine their agreement or refusal concerning: diagnosis, treatment (purpose, plans and methods), outcomes of care (including unanticipated outcomes), discharge plan, participation in medical research studies, organ transplantation/donation, etc. Within ethical boundaries, patients may discontinue or refuse treatment, request that the medical team explain and suggest alternative treatments, and reserve the right to make their own decisions.

3. Right to confidentiality

Patients' rights to confidentiality regarding their physical/health status and privacy will not be violated. Patients can expect that all medical records/reports and their personal privacy will be kept confidential unless the patient has given consent or disclosure is permitted by law. To ensure their privacy, patients may be informed that Individuals not directly involved in their care may not be present and that the number of guardians accompanying patients to consultation rooms may be limited.

4. Right to request consultation and mediation

In the event of a medical dispute, patients may request consultation and mediation from an internal or external agency (Korea Consumer Agency, Korea Medical Dispute Mediation and Arbitration Agency).

5. Right to have values and beliefs respected

Patients will not be discriminated against because of their culture, religious values, or beliefs, and their rights will not be violated.

6. Right to receive care in a safe setting

Patients have the right to receive hospital-provided care where the patient’s medical information is protected and patient safety can be assured. In addition, patients have the right to be protected from possible dangers that can occur in a hospital and to have stability of mind and body.

Patients' Responsibilities

1. Responsibility to trust and respect the medical team

Patients must accurately inform the medical team of their health condition and must trust and respect the medical team's treatment plan. Patients may be responsible for consequences that result from not following instructions.

2. Responsibility to not use dishonest methods for medical treatment

Patients must reveal their identity before receiving any medical care and must not use false or dishonest methods, such as seeking medical care under disguised ownership.

3. Responsibility to abide by all hospital regulations

Patients are expected to treat all hospital staff and other patients with courtesy and respect; to abide by all hospital rules; and to earnestly fulfill their financial obligation to the hospital. Also, patients and their family members are expected to participate in all safety regulations.